Sempre Health ads

This Heart Month, we are highlighting Susan's Sempre Health story. After experiencing a clot, Susan learned she would need to be on a blood thinner for the rest of her life. At $55 a month, the cost added stress to an already serious diagnosis. With Sempre, Susan's copay dropped to $15, and continue to decrease as she fills on-time. More importantly, the financial uncertainty disappeared. We are proud to support patients like Susan so they can focus on their health and what matters most. To learn more, visit: semprehealth.com

"Sometimes we just need somebody to care a little bit, and your company cares." Katheryn, a Sempre Health patient, shares how the program's dynamic discounts make it possible to afford her diabetes medication — helping her stay on track, avoid complications, and keep her doctors saying, "You’re doing a good job." Watch Katheryn’s story and learn more at semprehealth.com

We’re excited to announce a new partnership with Prime Therapeutics that will expand Sempre’s behavior-based pricing model to millions nationwide. This collaboration builds on our proven success with leading health plans like Blue Cross NC, where Sempre members saw $4.7 million in savings and a 15% improvement in adherence. We’re proud to welcome Prime to our growing network of health plans, PBMs, and life science companies working to make medications more affordable, adherence more achievable, and healthcare more human. Read the full release: https://lnkd.in/efie9-7B

"The whole program really has been fantastic. At some point, I even lost track of the date that I needed to refill by, so the reminder is perfect for me." Hear from Karen, a Sempre Health patient since 2023, who relies on the program's timely refill reminders, dynamic discounts, and real-time support to make managing multiple prescriptions simple and hassle-free. Sempre is proud to help patients like Karen stay on track with their medications. Watch her story and learn more at semprehealth.com

I spoke to 10 market access leaders and kept hearing one recurring question: “How do I know I’m not just giving money away?” Affordability is the only GTN line spent claim-by-claim, on a known patient, and it’s managed with the least precision. My guest post on Drug Channels on why, and what a better playbook looks like: https://lnkd.in/g5a8b5Bv Thank you Adam Fein and Drug Channels Institute, an HMP Global Company!

Help more patients start and stay on therapy without growing your GTN spend. As you plan for 2027, see how Sempre Health makes affordability smarter.